Par Drugs And Chemicals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30.06.2025
PAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Par Drugs and Chemicals has submitted a routine compliance certificate to NSE for the quarter ended June 30, 2025, as required under SEBI's Depositories Regulations. The certificate, issued by the company's Registrar and Share Transfer Agent (MUFG Intime India Private Limited), confirms that all securities received for dematerialization during the quarter were properly processed, verified, and reflected in the company's register of members within prescribed timelines. No rejected certificates or irregularities are flagged in the filing. This is a standard quarterly regulatory submission with no material business or financial details disclosed.
This is a routine compliance filing with no impact on the stock price or shareholder value. It simply confirms the company is meeting its regulatory obligations regarding share dematerialization processes.